ScreenerHero
HBPHelix BioPharma Corp.
TSX · CA · Healthcare · Biotechnology · helixbiopharma.com
2.040CAD+2.00%Mkt Cap: 111.25M $P/E: —

Helix BioPharma Corp. a clinical-stage biopharmaceutical company developing therapies in the field of immune-oncology in Canada. Its product pipeline comprises L-DOS47, a clinical-stage antibody-enzyme conjugate (AEC) th…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
ARGENX SE
$60.19BUSDP/E 39.1
UCB
UCB SA
$45.16BUSDP/E 19.2
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.17BUSDP/E 26.2
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap111.25M $
Enterprise Value109.44M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-2.42M $
Revenue/Share—
Last Price2.040 CAD
Fiscal Year EndJul 2025
MR QuarterApr 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-18.18
PEG—
EV/EBITDA-46.17
EV/Revenue—
P/S—
P/B10.42
EPS (TTM)-0.04
EPS (Forward)-0.11
52W Range
0.980024% of range5.400
52W High5.400 CAD
52W Low0.9800 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-49.99%
ROA-18.19%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.80M $
CapEx (TTM)10.20K $
FCF Margin—
FCF Yield1.33%
Net Debt-1.81M $
Net Debt/EBITDA0.76
Balance Sheet
Debt/Equity2.45
Current Ratio0.45
Quick Ratio0.43
Book Value/Sh0.1920 CAD
Cash/Share0.0370 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateAug 16, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.76.38M
Float45.92M
Insiders28.95%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Float0.00%
Short % Out.0.00%
Shares Short79
Short (prev mo.)445
Technical
SMA 501.526 (+33.7%)
SMA 2001.876 (+8.8%)
Beta-0.35
S&P 52W Chg18.16%
Avg Vol (30d)1.26K
Avg Vol (10d)2.92K
Technical Indicators
RSI (14)85.3
MACD0.1021
MACD Signal0.0510
MACD Hist.+0.0511
BB Upper1.903 CAD
BB Middle1.566 CAD
BB Lower1.229 CAD
BB Width43.06%
ATR (14)0.0941 CAD
Vol Ratio (20d)1.55x